Active Ingredient: SODIUM POLYSTYRENE SULFONATE
Proprietary Name: KAYEXALATE
Dosage Form; Route of Administration: POWDER; ORAL, RECTAL
Strength: 453.6GM/BOT **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N011287
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: CONCORDIA PHARMACEUTICALS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information